New patent expiration for Purdue Pharma drug HYSINGLA ER
Annual Drug Patent Expirations for HYSINGLA+ER Hysingla Er is a drug marketed by Purdue Pharma Lp and is included in […]
New patent expiration for Purdue Pharma drug HYSINGLA ER Read Post »
Annual Drug Patent Expirations for HYSINGLA+ER Hysingla Er is a drug marketed by Purdue Pharma Lp and is included in […]
New patent expiration for Purdue Pharma drug HYSINGLA ER Read Post »
Annual Drug Patent Expirations for NUCYNTA Nucynta is a drug marketed by Collegium Pharm Inc and is included in three
New patent expiration for Collegium Pharm drug NUCYNTA Read Post »
Annual Drug Patent Expirations for NUCYNTA+ER Nucynta Er is a drug marketed by Collegium Pharm Inc and is included in
New patent expiration for Collegium Pharm drug NUCYNTA ER Read Post »
MACRILEN (macimorelin acetate) Novo Patent: 6,861,409 Expiration: Aug 1, 2022 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of July 31, 2022 Read Post »
Annual Drug Patent Expirations for MACRILEN Macrilen is a drug marketed by Novo and is included in one NDA. It
Annual Drug Patent Expirations for ADDYI Addyi is a drug marketed by Sprout Pharms and is included in one NDA.
New patent expiration for Sprout Pharms drug ADDYI Read Post »
Annual Drug Patent Expirations for EVAMIST Evamist is a drug marketed by Padagis Us and is included in one NDA.
New patent expiration for Padagis Us drug EVAMIST Read Post »
MACRILEN (macimorelin acetate) Novo Patent: 6,861,409 Expiration: Aug 1, 2022 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of July 31, 2022 Read Post »
Annual Drug Patent Expirations for BEYAZ Beyaz is a drug marketed by Bayer Hlthcare and is included in one NDA.
New patent expiration for Bayer Hlthcare drug BEYAZ Read Post »
Get fresh news and insights, drug patent expirations & more…